Work

Abstract 430: Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-430

Authors: Jessica Armand, Sungsoo Kim, Kibum Kim, Eugene Son, Minah Kim, Hee Won Yang

Institution: Columbia University Irving Medical Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409691366

Cites:

Cited by:

Related to: 10